Intravenous Proton Pump Inhibitors before Endoscopy in Bleeding Peptic Ulcer with High-Risk Stigmata: A Multicentre Comparative Study
BACKGROUND: It is not clear if starting intravenous proton pump inhibitors (IV PPI) before endoscopic therapy provides additional benefit over starting it afterward in patients with high-risk ulcer stigmata of peptic ulcer disease.
Saved in:
Main Authors: | Christopher N Andrews, Adrian Levy, Martin Fishman, Michael Hahn, Kenneth Atkinson, Peter Kwan, Robert Enns |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2005/476205 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Description of Prescribing Practices in Patients with Upper Gastrointestinal Bleeding Receiving Intravenous Proton-Pump Inhibitors: A Multicentre Evaluation
by: Robert Enns, et al.
Published: (2004-01-01) -
High or Nonhigh Doses of Proton Pump Inhibitors for Patients with Peptic Ulcer Bleeding?
by: Yu-Hsi Hsieh, et al.
Published: (2013-01-01) -
A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding
by: Lung-Sheng Lu, et al.
Published: (2012-01-01) -
Can the Presence of Endoscopic High-Risk Stigmata be Bredicted before Endoscopy? A Multivariable Analysis Using the RUGBE Database
by: Yen-I Chen, et al.
Published: (2014-01-01) -
Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings
by: M. A. Evseyev, et al.
Published: (2010-06-01)